On March 13, 2020, the President of the United States declared a national emergency in reaction to the coronavirus disease of 2019 (COVID-19) pandemic. [1] With reports of laboratory-confirmed instances in all 50 states at the time,[2] disruptions in the ability of the U. S. physical care formula were expected. The U. S. Department of Health and Prevention to continue providing preventive and other non-urgent care. In addition, many states and localities have issued stay-at-home or stay-at-home orders to slow the spread of COVID-19, restricting activities outside the home to essential activities. [3] On March 24, CDC issued rules emphasizing the importance of the youth care and immunization regimen, especially for youth ≤ 24 months of age, when vaccines are recommended for many formative years. *
Two lines of evidence were tested to assess the effect of the pandemic on pediatric immunization in the United States: information on CDC’s orders for childhood vaccine providers (VFCs) and information on vaccine management from the Vaccine Safety Data Link (VSD). Immunization policy is the classic measure used to evaluate vaccine use; However, providers’ prescriptions and dosages administered are two oblique measures that can be easily taken.
VFC is a national program that provides federally purchased vaccines to approximately 50% of America’s youth ages 0-18. † Cumulative doses of VFC-funded vaccines ordered through fitness service providers in weekly periods for two eras (January 7, 2019 to April 21, 2019 [era 1] and January 6, 2020 to April 19, 2020 [era 2]) and calculated the differences in cumulative weekly doses of requested vaccines between era 2 and era 1 for all non-influenza vaccines § that the Advisory Committee on Immunization Practices (ACIP) recommends for young people and, for example, measles vaccines. ¶ VSD is a collaborative effort between the immunization program’s Office of Safety and 8 US physical care organizations serving publicly and privately insured patients . ** Total number of measles doses administered weekly at VSD sites. Period 2 was compared between two pediatric age groups: youth older than 24 months and older than 24 months to 18 years.
Vaccine tracking formula data imply a notable decrease in orders for CFV-funded and ACIP-recommended measles and influenza vaccines in formative years in Period 2 compared to Period 1 (Figure). The decline began the week after a national emergency was declared; Similar declines were also seen in orders for other vaccines. VSD data show a corresponding minimum in measles vaccine controls as of the week of March 16, 2020. The decrease was smaller in children older than 24 months than in older children (Figure). The next building increase in vaccine control in March expired is greater in younger children than in older children.
Digit.
Weekly adjustments to Childhood Vaccine Program (VFC) provider orders* and administered doses of VSD (Safety Data Link Vaccine)† for pediatric vaccines in the regimen: United States, January 6 through April 19, 2020 *HRV knowledge makes the difference in cumulative doses of HRV – funded influenza and measles vaccines ordered through fitness care in weekly periods January 7 through April 21, 2019 and January 6 through April 19, 2020. 24 months and >24 months–18 years).
The really extensive relief in VFC-funded pediatric vaccine orders following the COVID-19 emergency declaration is consistent with adjustments in vaccine delivery to youth in the VSD population receiving care through 8 primary U. S. physical care organizations. UU. La smaller decline in measles vaccine management in children older ≤ 24 months suggests that system-level methods are being implemented to prioritize child care and immunization for this age organization. methods implemented through VSD fitnesscare organizations to advertise childhood vaccines in the context of the pandemic, adding patient awareness with delayed vaccinations and modifying workplace workflows to minimize contact between patients. [4] An evaluation of national and local immunization policy is needed to quantify the effect on U. S. children of all ages and prioritize intervention spaces.
The current COVID-19 pandemic reminds us of the importance of vaccination. Known decreases in orders for pediatric regimen vaccines and doses administered may mean that American children and their communities face increased risks of outbreaks of vaccine-preventable diseases. Parents’ considerations about their children’s potential exposure to COVID-19 visits to physically fit youth may be contributing to the observed declines. [5] To the extent that this is the case, it is imperative to remind parents of the important need to protect their children from serious vaccine-preventable diseases, even as the COVID-19 pandemic continues. As needs for relaxed social distancing increase, young people who are not protected by vaccines will be more vulnerable to diseases such as measles. In response, continued coordinated efforts between physical care providers and public physical activity officials at the local, state, and federal levels will be required to achieve immediate detection. -up vaccination.
Acknowledgements Knowledge link on vaccine protection; Leslie Kuckler, Jingyi Zhu, HealthPartners Institute, Minneapolis, Minnesota.
Morbidity and Mortality Weekly Report. 2020;69(19):591-593. © 2020 Centers for Disease Control and Prevention (CDC)
*https://www. cdc. gov/coronavirus/2019-ncov/hcp/pediatric-hcp. html. †Children ≤18 years of age are eligible if they are Medicaid-eligible, uninsured, American Indian/Alaska Native, or underinsured, and vaccinated at federally qualified fitness centers, rural fitness clinics, or provider sites with an approved delegation agreement with State Public Health. https://www. cdc. gov/vaccines/programs/vfc/index. html. § https://www. cdc. gov/vaccines/schedules/hcp/imz/child-adolescent. html. ¶In the United States, two measles vaccines are licensed for use as a regimen in youth: measles-mumps-rubella (MMR) and an MMR/varicella combination (MMRV). The Advisory Committee on Immunization Practices recommends that young Americans get a 2-dose series of measles vaccine at 12 to 15 months of age and 4 to 6 years of age. **https://www. cdc. gov /vaccinesafety/ensuringsafety/monitoring /vd/.
Jeanne M. Santoli, MD1, Megan C. Lindley, MPH1, Malini B. DeSilva, MD2, Elyse O. Kharbanda, MD2, Matthew F. Daley, MD3, Lisa Galloway1, Julianne Gee, MPH4, Mick Glover5, Ben Herring6, Yoonjae Kang, MPH1, Paul Lucas, MS1, Cameron Noblit, MPH1, Jeanne Tropper, MPH, MS, MBA1, Tara Vogt, PhD1 y Eric Weintraub, MPH4 1Division of Immunization Services, National Center for Immunization and Respiratory Diseases, CDC; 2HealthPartners Institute, Minneapolis, Minnesota; 3Health Research Institute, Kaiser Permanente Colorado, Aurora, Colorado; 4Division of Health Care Quality Promotion, National Center for Emerging Zoonotic and Infectious Diseases, CDC; 5Total Solutions, Inc. , Madison, Alabama; 6Carter Consulting, Inc. , Atlanta, Georgia.
Jeanne Santoli correspondent, jsantoli@cdc. gov, 404-639-8877.
All authors completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Digit.
Digit.
Weekly adjustments to Childhood Vaccine Program (VFC) provider orders* and administered doses of VSD (Safety Data Link Vaccine)† for pediatric vaccines in the regimen: United States, January 6 through April 19, 2020 *HRV knowledge makes the difference in cumulative doses of HRV – funded influenza and measles vaccines ordered through fitness care in weekly periods January 7 through April 21, 2019 and January 6 through April 19, 2020. 24 months and >24 months–18 years).
You’ve already decided on My Alerts
Click on the subject line below to receive emails when new items become available.